Journal
IMMUNITY
Volume 35, Issue 6, Pages 986-996Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2011.10.015
Keywords
-
Categories
Funding
- NIH [1R01NS059996, 5T32HL066987-09, R01NS045937, R01NS035685, R37NS030843, R01A1044880, P01A1039671, P01NS038037]
- Javits Neuroscience Investigator Award
- National Multiple Sclerosis Society (NMSS) [TA3014A1/1, RG-2571]
- Boehringer Ingelheim Fonds
Ask authors/readers for more resources
Ectopic lymphoid follicles are hallmarks of chronic autoimmune inflammatory diseases such as multiple sclerosis (MS), rheumatoid arthritis, Sjogren's syndrome, and myasthenia gravis. However, the effector cells and mechanisms that induce their development are unknown. Here we showed that in experimental autoimmune encephalomyelitis (EAE), the animal model of MS, Th17 cells specifically induced ectopic lymphoid follicles in the central nervous system (CNS). Development of ectopic lymphoid follicles was partly dependent on the cytokine interleukin 17 (IL-17) and on the cell surface molecule Podoplanin (Pdp), which was expressed on Th17 cells, but not on other effector T cell subsets. Pdp was also crucial for the development of secondary lymphoid structures: Pdp-deficient mice lacked peripheral lymph nodes and had a defect in forming normal lymphoid follicles and germinal centers in spleen and lymph node remnants. Thus, Th17 cells are uniquely endowed to induce tissue inflammation, characterized by ectopic lymphoid follicles within the target organ.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available